/Companies

IonPath

4 known investors

Find your way into IonPath

Sign up to see every warm intro you have to IonPath

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the IonPath team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.

Investors · 4

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does IonPath do?
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
Who are IonPath's investors?
IonPath's investors include Hemisphere Ventures LLC, Norwich Ventures, Vertical Venture Partners, Samsara BioCapital.